Cargando…
Humans Vary, So Cardiac Models Should Account for That Too!
The utilization of mathematical modeling and simulation in drug development encompasses multiple mathematical techniques and the location of a drug candidate in the development pipeline. Historically speaking they have been used to analyze experimental data (i.e., Hill equation) and clarify the invo...
Autores principales: | Wiśniowska, Barbara, Tylutki, Zofia, Polak, Sebastian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5613127/ https://www.ncbi.nlm.nih.gov/pubmed/28983251 http://dx.doi.org/10.3389/fphys.2017.00700 |
Ejemplares similares
-
Top-down, Bottom-up and Middle-out Strategies for Drug Cardiac Safety Assessment via Modeling and Simulations
por: Tylutki, Zofia, et al.
Publicado: (2016) -
A four-compartment PBPK heart model accounting for cardiac metabolism - model development and application
por: Tylutki, Zofia, et al.
Publicado: (2017) -
Drug-drug interactions and QT prolongation as a commonly assessed cardiac effect - comprehensive overview of clinical trials
por: Wiśniowska, Barbara, et al.
Publicado: (2016) -
Physiologically based pharmacokinetic-quantitative systems toxicology and safety (PBPK-QSTS) modeling approach applied to predict the variability of amitriptyline pharmacokinetics and cardiac safety in populations and in individuals
por: Tylutki, Zofia, et al.
Publicado: (2018) -
How circadian variability of the heart rate and plasma electrolytes concentration influence the cardiac electrophysiology – model-based case study
por: Wiśniowska, Barbara, et al.
Publicado: (2021)